Risk of Complications After Endoscopic Retrograde Cholangiopancreatography in Pregnancy: A Propensity-Matched Analysis.
Complications
Endoscopic retrograde cholangiopancreatography
Pancreatitis
Pregnancy
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
07
06
2023
accepted:
11
09
2023
pubmed:
24
9
2023
medline:
24
9
2023
entrez:
23
9
2023
Statut:
ppublish
Résumé
Studies have suggested higher complication rates after endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy. We performed a propensity-matched cohort analysis to assess the risk of ERCP-related complications among pregnant women in the United States. The TriNetX database was analyzed to identify pregnant and non-pregnant females between 18 and 50 years of age who underwent ERCP. One-to-one propensity score matching was performed for age and race. Outcomes included risk of post-ERCP pancreatitis (PEP), gastrointestinal (GI) bleeding, perforation within 7 days, and infections within 30 days of ERCP. Subgroup analysis was performed to assess the risk of PEP based on indication for ERCP. The risk of PEP was higher in the pregnant cohort compared to controls, 10.3% vs 6.08%, adjusted odds ratio (aOR) 1.77, 95% confidence interval (CI) 1.20-2.61; p = 0.003. We found no difference in the risk of GI bleeding, perforation, and infections between the two cohorts. There was no difference in the risk of PEP in the pregnant cohort compared to controls who underwent ERCP for acute choledocholithiasis (4.2% vs 2.1%, aOR 1.98, 95% CI 0.97-4.03, p = 0.5) or ascending cholangitis (18.6% vs 14.7%, aOR 1.32, 95% CI 0.52-3.39, p = 0.55). There was no difference in the risk of PEP in the pregnant cohort after sensitivity analysis based on age, race, obesity, and indomethacin use. Pregnant females are at an increased risk of PEP but not GI bleeding, perforation, and infections when compared to non-pregnant controls. Clinicians should be cautious when proceeding with ERCP during pregnancy.
Sections du résumé
BACKGROUND
BACKGROUND
Studies have suggested higher complication rates after endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy.
AIMS
OBJECTIVE
We performed a propensity-matched cohort analysis to assess the risk of ERCP-related complications among pregnant women in the United States.
METHODS
METHODS
The TriNetX database was analyzed to identify pregnant and non-pregnant females between 18 and 50 years of age who underwent ERCP. One-to-one propensity score matching was performed for age and race. Outcomes included risk of post-ERCP pancreatitis (PEP), gastrointestinal (GI) bleeding, perforation within 7 days, and infections within 30 days of ERCP. Subgroup analysis was performed to assess the risk of PEP based on indication for ERCP.
RESULTS
RESULTS
The risk of PEP was higher in the pregnant cohort compared to controls, 10.3% vs 6.08%, adjusted odds ratio (aOR) 1.77, 95% confidence interval (CI) 1.20-2.61; p = 0.003. We found no difference in the risk of GI bleeding, perforation, and infections between the two cohorts. There was no difference in the risk of PEP in the pregnant cohort compared to controls who underwent ERCP for acute choledocholithiasis (4.2% vs 2.1%, aOR 1.98, 95% CI 0.97-4.03, p = 0.5) or ascending cholangitis (18.6% vs 14.7%, aOR 1.32, 95% CI 0.52-3.39, p = 0.55). There was no difference in the risk of PEP in the pregnant cohort after sensitivity analysis based on age, race, obesity, and indomethacin use.
CONCLUSION
CONCLUSIONS
Pregnant females are at an increased risk of PEP but not GI bleeding, perforation, and infections when compared to non-pregnant controls. Clinicians should be cautious when proceeding with ERCP during pregnancy.
Identifiants
pubmed: 37741950
doi: 10.1007/s10620-023-08112-y
pii: 10.1007/s10620-023-08112-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4266-4273Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Kozarek RA. The Past, Present, and Future of Endoscopic Retrograde Cholangiopancreatography. Gastroenterol Hepatol (N Y). 2017;13:620–2. PubMed PMID: 29230140; PubMed Central PMCID: PMC5718180.
Tarikci Kilic E, Kahraman R, Ozdil K. Evaluation of Safety and Outcomes of Endoscopic Retrograde Cholangiopancreatography in 1337 Patients at a Single Center. Medeni Med J. 2019;34:290-6. Epub 20190927. doi: https://doi.org/10.5222/MMJ.2019.58265 . PubMed PMID: 32821451; PubMed Central PMCID: PMC7433733.
Yun DY, Han J, Oh JS, Park KW, Shin IH, Kim HG. Is endoscopic retrograde cholangiopancreatography safe in patients 90 years of age and older? Gut Liver. 2014;8:552-6. Epub 20140224. doi: https://doi.org/10.5009/gnl13310 . PubMed PMID: 25228977; PubMed Central PMCID: PMC4164253.
Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y). 2013;9:496-504. PubMed PMID: 24719597; PubMed Central PMCID: PMC3980992.
Solanki S, Kichloo A, Dahiya DS, Solanki D, Singh J, Wani F, et al. Endoscopic Retrograde Cholangiopancreatography (ERCP) in Patients With Liver Cirrhosis: Analysis of Trends and Outcomes From the National Inpatient Sample Database. J Clin Gastroenterol. 2022;56:618-26. Epub 20210609. doi: https://doi.org/10.1097/MCG.0000000000001573 . PubMed PMID: 34107514; PubMed Central PMCID: PMC9257052.
Moffatt DC, Yu BN, Yie W, Bernstein CN. Trends in utilization of diagnostic and therapeutic ERCP and cholecystectomy over the past 25 years: a population-based study. Gastrointest Endosc. 2014;79:615–22. Epub 20131008. doi: https://doi.org/10.1016/j.gie.2013.08.028 . PubMed PMID: 24119510.
Dahiya DS, Perisetti A, Sharma N, Inamdar S, Goyal H, Singh A, et al. Racial disparities in endoscopic retrograde cholangiopancreatography (ERCP) utilization in the United States: are we getting better? Surg Endosc. 2022. Epub 20220819. doi: https://doi.org/10.1007/s00464-022-09535-w . PubMed PMID: 35986223.
Okano N, Ito K, Takuma K, Hara S, Igarashi Y. Prevention and management of ERCP-related complications. Mini-invasive Surgery. 2021;5:29. https://doi.org/10.20517/2574-1225.2021.15 .
doi: 10.20517/2574-1225.2021.15
Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781–8. Epub 20070517. doi: https://doi.org/10.1111/j.1572-0241.2007.01279.x . PubMed PMID: 17509029.
Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81:143–9.e9. Epub 20140801. doi: https://doi.org/10.1016/j.gie.2014.06.045 . PubMed PMID: 25088919.
Williams EJ, Taylor S, Fairclough P, Hamlyn A, Logan RF, Martin D et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007;39:793–801. https://doi.org/10.1055/s-2007-966723 . (PubMed PMID: 17703388).
doi: 10.1055/s-2007-966723
pubmed: 17703388
Celaj S, Kourkoumpetis T. Gallstones in Pregnancy. JAMA. 2021;325:2410-. doi: https://doi.org/10.1001/jama.2021.4502 .
Hahm JS, Park JY, Song SC, Cho YJ, Moon KH, Song YH et al. Gallbladder motility change in late pregnancy and after delivery. Korean J Intern Med. 1997;12:16–20. https://doi.org/10.3904/kjim.1997.12.1.16.PubMedPMID:9159032;PubMedCentralPMCID:PMC4531973 .
doi: 10.3904/kjim.1997.12.1.16.PubMedPMID:9159032;PubMedCentralPMCID:PMC4531973
pubmed: 9159032
pmcid: 4531973
Fine S, Beirne J, Delgi-Esposti S, Habr F. Continued evidence for safety of endoscopic retrograde cholangiopancreatography during pregnancy. World J Gastrointest Endosc. 2014;6:352–358. https://doi.org/10.4253/wjge.v6.i8.352.PubMedPMID:25132918;PubMedCentralPMCID:PMC4133414 .
doi: 10.4253/wjge.v6.i8.352.PubMedPMID:25132918;PubMedCentralPMCID:PMC4133414
pubmed: 25132918
pmcid: 4133414
Schwulst SJ, Son M. Management of Gallstone Disease During Pregnancy. JAMA Surg. 2020;155:1162–1163. https://doi.org/10.1001/jamasurg.2020.3683 . (PubMed PMID: 32997134).
doi: 10.1001/jamasurg.2020.3683
pubmed: 32997134
Molvar C, Glaenzer B. Choledocholithiasis: Evaluation, Treatment, and Outcomes. Semin Intervent Radiol. 2016;33:268–276. https://doi.org/10.1055/s-0036-1592329.PubMedPMID:27904245;PubMedCentralPMCID:PMC5088099 .
doi: 10.1055/s-0036-1592329.PubMedPMID:27904245;PubMedCentralPMCID:PMC5088099
pubmed: 27904245
pmcid: 5088099
Kundumadam S, Fogel EL, Gromski MA. Gallstone pancreatitis: general clinical approach and the role of endoscopic retrograde cholangiopancreatography. Korean J Intern Med. 2021;36:25–31. Epub 20210101. doi: https://doi.org/10.3904/kjim.2020.537 . PubMed PMID: 33147903; PubMed Central PMCID: PMC7820643.
Ahmed M. Acute cholangitis - an update. World J Gastrointest Pathophysiol. 2018;9:1–7. https://doi.org/10.4291/wjgp.v9.i1.1.PubMedPMID:29487761;PubMedCentralPMCID:PMC5823698 .
doi: 10.4291/wjgp.v9.i1.1.PubMedPMID:29487761;PubMedCentralPMCID:PMC5823698
pubmed: 29487761
pmcid: 5823698
Oto A, Ernst R, Ghulmiyyah L, Hughes D, Saade G, Chaljub G. The role of MR cholangiopancreatography in the evaluation of pregnant patients with acute pancreaticobiliary disease. Br J Radiol. 2009;82:279–85. Epub 20081124. doi: https://doi.org/10.1259/bjr/88591536 . PubMed PMID: 19029218.
Date RS, Kaushal M, Ramesh A. A review of the management of gallstone disease and its complications in pregnancy. Am J Surg. 2008;196:599–608. Epub 20080709. doi: https://doi.org/10.1016/j.amjsurg.2008.01.015 . PubMed PMID: 18614143.
Azab M, Bharadwaj S, Jayaraj M, Hong AS, Solaimani P, Mubder M et al. Safety of endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy: A systematic review and meta-analysis. Saudi J Gastroenterol. 2019;25:341–354. https://doi.org/10.4103/sjg.SJG_92_19.PubMedPMID:31744939;PubMedCentralPMCID:PMC6941455 .
doi: 10.4103/sjg.SJG_92_19.PubMedPMID:31744939;PubMedCentralPMCID:PMC6941455
pubmed: 31744939
pmcid: 6941455
Cappell MS, Stavropoulos SN, Friedel D. Systematic review of safety and efficacy of therapeutic endoscopic-retrograde-cholangiopancreatography during pregnancy including studies of radiation-free therapeutic endoscopic-retrograde-cholangiopancreatography. World J Gastrointest Endosc. 2018;10:308–321. https://doi.org/10.4253/wjge.v10.i10.308.PubMedPMID:30364767;PubMedCentralPMCID:PMC6198312 .
doi: 10.4253/wjge.v10.i10.308.PubMedPMID:30364767;PubMedCentralPMCID:PMC6198312
pubmed: 30364767
pmcid: 6198312
Inamdar S, Berzin TM, Sejpal DV, Pleskow DK, Chuttani R, Sawhney MS, et al. Pregnancy is a Risk Factor for Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in a National Cohort Study. Clin Gastroenterol Hepatol. 2016;14:107–14. Epub 20150505. doi: https://doi.org/10.1016/j.cgh.2015.04.175 . PubMed PMID: 25952311.
Tang SJ, Mayo MJ, Rodriguez-Frias E, Armstrong L, Tang L, Sreenarasimhaiah J, et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc. 2009;69:453–61. Epub 20090110. doi: https://doi.org/10.1016/j.gie.2008.05.024 . PubMed PMID: 19136111.
Sethi A, Banerjee S, Chahal P. Advanced Endoscopic Procedures in Pregnancy. Am J Gastroenterol. 2022;117:39–43. https://doi.org/10.14309/ajg.0000000000001959 . (PubMed PMID: 36194032).
doi: 10.14309/ajg.0000000000001959
pubmed: 36194032
Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85:32–47. Epub 20160818. doi: https://doi.org/10.1016/j.gie.2016.06.051 . PubMed PMID: 27546389.
Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52:127–49. Epub 20191220. doi: https://doi.org/10.1055/a-1075-4080 . PubMed PMID: 31863440.
Storm AC, Abu Dayyeh BK, Petersen BT, Chandrasekhara V, Levy MJ, Wengert HN et al. Indomethacin for post-ERCP pancreatitis: Prophylaxis at what cost? Gastrointest Endosc. 2020;91:207–208. https://doi.org/10.1016/j.gie.2019.09.008 . (PubMed PMID: 31865994).
doi: 10.1016/j.gie.2019.09.008
pubmed: 31865994
Elmunzer BJ, Hernandez I, Gellad WF. The Skyrocketing Cost of Rectal Indomethacin. JAMA Intern Med. 2020;180:631–632. https://doi.org/10.1001/jamainternmed.2020.0099.PubMedPMID:32150228;PubMedCentralPMCID:PMC7483935 .
doi: 10.1001/jamainternmed.2020.0099.PubMedPMID:32150228;PubMedCentralPMCID:PMC7483935
pubmed: 32150228
pmcid: 7483935
Dimitroulis D, Antoniou E, Karidis NP, Kontzoglou K, Kouraklis G. Surgical control of life-threatening post-ERCP bleeding with a gelatin matrix-thrombin hemostatic agent. Int J Surg Case Rep. 2012;3:471–3. Epub 20120602. doi: https://doi.org/10.1016/j.ijscr.2012.05.014 . PubMed PMID: 22743012; PubMed Central PMCID: PMC3397303.
Wu HM, Dixon E, May GR, Sutherland FR. Management of perforation after endoscopic retrograde cholangiopancreatography (ERCP): a population-based review. HPB (Oxford). 2006;8:393–399. https://doi.org/10.1080/13651820600700617.PubMedPMID:18333093;PubMedCentralPMCID:PMC2020744 .
doi: 10.1080/13651820600700617.PubMedPMID:18333093;PubMedCentralPMCID:PMC2020744
pubmed: 18333093
pmcid: 2020744
Singh VK. Managing Perforations Related to Endoscopic Retrograde Cholangiopancreatography. Gastroenterol Hepatol (N Y). 2016;12:260–2. PubMed PMID: 27231459; PubMed Central PMCID: PMC4872858.
Friedel D, Stavropoulos S, Iqbal S, Cappell MS. Gastrointestinal endoscopy in the pregnant woman. World J Gastrointest Endosc. 2014;6:156–167. https://doi.org/10.4253/wjge.v6.i5.156.PubMedPMID:24891928;PubMedCentralPMCID:PMC4024488 .
doi: 10.4253/wjge.v6.i5.156.PubMedPMID:24891928;PubMedCentralPMCID:PMC4024488
pubmed: 24891928
pmcid: 4024488
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393. https://doi.org/10.1016/s0016-5107(91)70740-2 . PubMed PMID: 2070995.
doi: 10.1016/s0016-5107(91)70740-2
pubmed: 2070995